What is Klotho Neurosciences Inc. Annual Net Profit?

Klotho Neurosciences Inc. Annual Net Profit fell 769.36% in the last year to $6.15 M. Its sector's average net profit growth for the last fiscal year was 17.56%.

What is Klotho Neurosciences Inc. Price to Earning Ratio?

Klotho Neurosciences Inc. Price to Earning Ratio is -0.87, which is negative.

What is Klotho Neurosciences Inc. Stock Price?

Klotho Neurosciences Inc. Stock Price fell 98.45% and underperformed its sector by 114.5% in the past year.

What is Klotho Neurosciences Inc. Quarterly Net profit?

Klotho Neurosciences Inc. Quarterly Net profit fell 1,534.46% YoY to $2.07 M. Its sector's average net profit growth YoY for the quarter was 36.53%.

What is Klotho Neurosciences Inc. Mutual Fund Holding?

Klotho Neurosciences Inc. Mutual Fund Holding increased by 0.01% in the last quarter to 7.34.

What is Klotho Neurosciences Inc. Institutional Holding?

Klotho Neurosciences Inc. Institutional Holding remained the same in the last quarter at 18.01%.

How is the Klotho Neurosciences Inc. today?

The Klotho Neurosciences Inc. today is trading in the down by 0.00% at 0.17.

How has Klotho Neurosciences Inc. performed historically?

The Klotho Neurosciences Inc. is currently trading down 0.00% on an intraday basis in the past week the index rose 6.25%. The index has been down -63.83% in the past quarter and fell -98.45% in the past year. You can view this in the overview section.

Klotho Neurosciences Inc. XNAS: KLTO

Klotho Neurosciences Inc. Live Share Price Today, Share Analysis and Chart

Name: Klotho Neurosciences Inc.: Is Infosys Ltd. worth buying?
Item: Klotho Neurosciences Inc.
Rating: 0.31441675
Author: Trendlyne DVM scores

Download real time

0.17 0.00 (0.00%)

98.70% Fall from 52W High

60,587 XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

Klotho Neurosciences Inc. Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	4.8
PE TTM Negative PE TTM Unavailable in chosen country	-0.9
Price to Book Below industry Median Unavailable in chosen country	4.1
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	18
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-1,534.5
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-1,056.5
Rel Perf vs Sector quarter% Unavailable in chosen country	-65.6

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

2.2 / 100

Technically Bearish

10.4 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Klotho Neurosciences Inc. Stock Price Analysis

Week Price Range 6.2% 1 Week return Unavailable in chosen country	0.2 (LTP) 0.10.2 LowHigh
Month Price Range -39.3% 1 Month return Unavailable in chosen country	0.2 (LTP) 0.10.3 LowHigh
52 Week Price Range -98.4% 1 Year return Unavailable in chosen country	0.2 (LTP) 0.113.1 LowHigh

View full Share Price History

Klotho Neurosciences Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Klotho Neurosciences Inc. Stock Analysis

Klotho Neurosciences Inc. stock analysis with key metrics, changes, and trends.

Klotho Neurosciences Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$6.15 M	769.36%	negative	Annual Net Profit fell 769.36% in the last year to $6.15 M. Its sector's average net profit growth for the last fiscal year was 17.56%.
Price to Earning Ratio	-0.87	-	negative	Price to Earning Ratio is -0.87, which is negative.
Stock Price	$0.17	-98.45%	negative	Stock Price fell 98.45% and underperformed its sector by 114.5% in the past year.
Quarterly Net profit	$2.07 M	1534.46%	negative	Quarterly Net profit fell 1,534.46% YoY to $2.07 M. Its sector's average net profit growth YoY for the quarter was 36.53%.
Mutual Fund Holding	7.34 %	0.01%	positive	Mutual Fund Holding increased by 0.01% in the last quarter to 7.34.
Institutional Holding	18.01 %	0%	neutral	Institutional Holding remained the same in the last quarter at 18.01%.

VIEW LESS

Loading data..

Klotho Neurosciences Inc. - Company Profile

What does Klotho Neurosciences Inc. do?

Redwoods Acquisition Corp is a is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

Dr. Shalom Z. Hirschman, M.D.

Independent Director

120 K

2024

Gross Remuneration

Year

Klotho Neurosciences Inc. Live Share Price Today, Share Analysis and Chart

98.70% Fall from 52W High

Klotho Neurosciences Inc. Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Klotho Neurosciences Inc. Stock Price Analysis

Week Price Range

Month Price Range

52 Week Price Range

Klotho Neurosciences Inc. Live Price Chart

Klotho Neurosciences Inc. Stock Analysis

Klotho Neurosciences Inc. stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 769.36% in the last year to $6.15 M. Its sector's average net profit growth for the last fiscal year was 17.56%.

Price to Earning Ratio is -0.87, which is negative.

Stock Price fell 98.45% and underperformed its sector by 114.5% in the past year.

Quarterly Net profit fell 1,534.46% YoY to $2.07 M. Its sector's average net profit growth YoY for the quarter was 36.53%.

Mutual Fund Holding increased by 0.01% in the last quarter to 7.34.

Institutional Holding remained the same in the last quarter at 18.01%.

Klotho Neurosciences Inc. - Company Profile

What does Klotho Neurosciences Inc. do?

Redwoods Acquisition Corp is a is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

Klotho Neurosciences Inc. Management structure

Dr. Joseph Sinkule, Pharm.D.

Chairman of the Board and Chief Executive Officer

Mr. Peter Moriarty

Chief Operating Officer

Mr. Jeffrey Brian LeBlanc

Chief Financial Officer and Principal Accounting Officer

Mr. Edward Cong Wang

Chief Financial Officer and Director

Dr. David Sandor, PhD

Chief Operating Officer

Mr. Rick Basse, C.P.A.

Interim Chief Financial Officer

Klotho Neurosciences Inc. Board of directors

Dr. Shalom Z. Hirschman, M.D.

Independent Director

Dr. Samuel M. Zentman, PhD

Independent Director

Mr. Jon W. Mcgarity

Independent Director

Mr. Edward Cong Wang

Director

Dr. Joseph Sinkule, Pharm.D.

Chairman of the Board and Chief Executive Officer

Mr. Peter Moriarty

Chief Business Officer and Director

Klotho Neurosciences Inc. FAQ

How is Klotho Neurosciences Inc. today?

Klotho Neurosciences Inc. today is trading in the red, and is down by 0.00% at 0.17.

How has Klotho Neurosciences Inc. performed historically?

Klotho Neurosciences Inc. is currently trading down 0.00% on an intraday basis. In the past week the stock rose 6.25%. stock has been down -63.83% in the past quarter and fell -98.45% in the past year. You can view this in the overview section.